Anticoagulants Market Size, Share, Trends & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI101807

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Major Cardiovascular Diseases by Key Countries
2. Overview of Novel Oral Anticoagulants (NOACs)
3. Pipeline Analysis
4. Key Industry Developments Such as Mergers & Acquisitions
5. New Product Launches
6. Regulatory Scenario in Key Countries
7. Reimbursement Scenario by Key Countries
Global Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. North America
  2. Europe
  3. Asia pacific
  4. Latin America
  5. Middle East & Africa
North America Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Competition Dashboard
4. Comparative Analysis – Major Players
  1. Bristol-Myers Squibb Company
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  2. Pfizer Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  3. Bayer AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  4. Janssen Pharmaceuticals, Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  5. Eisai Co., Ltd.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  6. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
Strategic Recommendations

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Major Cardiovascular Diseases by Key Countries
2. Overview of Novel Oral Anticoagulants (NOACs)
3. Pipeline Analysis
4. Key Industry Developments Such as Mergers & Acquisitions
5. New Product Launches
6. Regulatory Scenario in Key Countries
7. Reimbursement Scenario by Key Countries
Global Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. North America
  2. Europe
  3. Asia pacific
  4. Latin America
  5. Middle East & Africa
North America Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anticoagulants Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Disease Indication
  1. Pulmonary Embolism (PE)
  2. Deep Vein Thrombosis (DVT)
  3. Atrial Fibrillation
  4. Heart Attacks
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Injectable
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
5. Market Analysis – By Country
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Competition Dashboard
4. Comparative Analysis – Major Players
  1. Bristol-Myers Squibb Company
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  2. Pfizer Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  3. Bayer AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  4. Janssen Pharmaceuticals, Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  5. Eisai Co., Ltd.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
  6. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability))
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Anticoagulants Market Revenue Breakdown (US$ Mn, %) by Region, 2025-2034

Figure 2: Global Anticoagulants Market Value Share (%), by Disease Indication, 2025-2034

Figure 3: Global Anticoagulants Market Forecast (US$ Mn), by Pulmonary Embolism (PE), 2021-2034

Figure 4: Global Anticoagulants Market Forecast (US$ Mn), by Deep Vein Thrombosis (DVT), 2021-2034

Figure 5: Global Anticoagulants Market Forecast (US$ Mn), by Atrial Fibrillation, 2021-2034

Figure 6: Global Anticoagulants Market Forecast (US$ Mn), by Heart Attacks, 2021-2034

Figure 7: Global Anticoagulants Market Forecast (US$ Mn), by Others, 2021-2034

Figure 8: Global Anticoagulants Market Value Share (%), by Route of Administration, 2025-2034

Figure 9: Global Anticoagulants Market Forecast (US$ Mn), by Oral, 2021-2034

Figure 10: Global Anticoagulants Market Forecast (US$ Mn), by Injectable, 2021-2034

Figure 11: Global Anticoagulants Market Value Share (%), by Distribution Channel, 2025-2034

Figure 12: Global Anticoagulants Market Forecast (US$ Mn), by Hospitals Pharmacies, 2021-2034

Figure 13: Global Anticoagulants Market Forecast (US$ Mn), by Retail Pharmacies, 2021-2034

Figure 14: Global Anticoagulants Market Forecast (US$ Mn), by Online Pharmacies, 2021-2034

Figure 15: Global Anticoagulants Market Forecast (US$ Mn), by Others, 2021-2034

Figure 16: Global Anticoagulants Market Value (US$ Mn), by Region, 2025-2034

Figure 17: North America Anticoagulants Market Value (US$ Mn), by Disease Indication, 2025-2034

Figure 18: North America Anticoagulants Market Value Share (%), by Disease Indication, 2025

Figure 19: North America Anticoagulants Market Value (US$ Mn), by Route of Administration, 2025-2034

Figure 20: North America Anticoagulants Market Value Share (%), by Route of Administration, 2025

Figure 21: North America Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2025-2034

Figure 22: North America Anticoagulants Market Value Share (%), by Distribution Channel, 2025

Figure 23: North America Anticoagulants Market Value (US$ Mn), By Country, 2025-2034

Figure 24: North America Anticoagulants Market Value Share (%), By Country, 2025

Figure 25: Europe Anticoagulants Market Value (US$ Mn), by Disease Indication, 2025-2034

Figure 26: Europe Anticoagulants Market Value Share (%), by Disease Indication, 2025

Figure 27: Europe Anticoagulants Market Value (US$ Mn), by Route of Administration, 2025-2034

Figure 28: Europe Anticoagulants Market Value Share (%), by Route of Administration, 2025

Figure 29: Europe Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2025-2034

Figure 30: Europe Anticoagulants Market Value Share (%), by Distribution Channel, 2025

Figure 31: Europe Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2025-2034

Figure 32: Europe Anticoagulants Market Value Share (%), By Country/ Sub-region, 2025

Figure 33: Asia Pacific Anticoagulants Market Value (US$ Mn), by Disease Indication, 2025-2034

Figure 34: Asia Pacific Anticoagulants Market Value Share (%), by Disease Indication, 2025

Figure 35: Asia Pacific Anticoagulants Market Value (US$ Mn), by Route of Administration, 2025-2034

Figure 36: Asia Pacific Anticoagulants Market Value Share (%), by Route of Administration, 2025

Figure 37: Asia Pacific Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2025-2034

Figure 38: Asia Pacific Anticoagulants Market Value Share (%), by Distribution Channel, 2025

Figure 39: Asia Pacific Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2025-2034

Figure 40: Asia Pacific Anticoagulants Market Value Share (%), By Country/ Sub-region, 2025

Figure 41: Latin America Anticoagulants Market Value (US$ Mn), by Disease Indication, 2025-2034

Figure 42: Latin America Anticoagulants Market Value Share (%), by Disease Indication, 2025

Figure 43: Latin America Anticoagulants Market Value (US$ Mn), by Route of Administration, 2025-2034

Figure 44: Latin America Anticoagulants Market Value Share (%), by Route of Administration, 2025

Figure 45: Latin America Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2025-2034

Figure 46: Latin America Anticoagulants Market Value Share (%), by Distribution Channel, 2025

Figure 47: Latin America Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2025-2034

Figure 48: Latin America Anticoagulants Market Value Share (%), By Country/ Sub-region, 2025

Figure 49: Middle East & Africa Anticoagulants Market Value (US$ Mn), by Disease Indication, 2025-2034

Figure 50: Middle East & Africa Anticoagulants Market Value Share (%), by Disease Indication, 2025

Figure 51: Middle East & Africa Anticoagulants Market Value (US$ Mn), by Route of Administration, 2025-2034

Figure 52: Middle East & Africa Anticoagulants Market Value Share (%), by Route of Administration, 2025

Figure 53: Middle East & Africa Anticoagulants Market Value (US$ Mn), by Distribution Channel, 2025-2034

Figure 54: Middle East & Africa Anticoagulants Market Value Share (%), by Distribution Channel, 2025

Figure 55: Middle East & Africa Anticoagulants Market Value (US$ Mn), By Country/ Sub-region, 2025-2034

Figure 56: Middle East & Africa Anticoagulants Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Anticoagulants Market Share (%), By Company, 2025

List of Tables

Table 1: Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2021–2034

Table 2: Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021–2034

Table 3: Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021–2034

Table 4: Global Anticoagulants Market Revenue (US$ Mn) Forecast, by Region, 2021-2034

Table 5: North America Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2021-2034

Table 6: North America Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034

Table 7: North America Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034

Table 8: North America Anticoagulants Market Revenue (US$ Mn) Forecast, By Country, 2021-2034

Table 9: Europe Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2021-2034

Table 10: Europe Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034

Table 11: Europe Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034

Table 12: Europe Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2021-2034

Table 14: Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034

Table 15: Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034

Table 16: Asia Pacific Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2021-2034

Table 18: Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034

Table 19: Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034

Table 20: Latin America Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, by Disease Indication, 2021-2034

Table 22: Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034

Table 23: Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034

Table 24: Middle East & Africa Anticoagulants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 149

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com